Dualsystems Biotech
Pre-clinicalDualsystems used the LRC-TriCEPS technology with a large number of different cell lines, primary cells and tissue to identify the targets. Call +41447385000
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $13M
About
Dualsystems used the LRC-TriCEPS technology with a large number of different cell lines, primary cells and tissue to identify the targets. Call +41447385000
AntibodiesBiologics
Funding History
3Total raised:$13M
Seed$8MNov 15, 2021
Seed$2.5MJun 15, 2021
Grant$2.5MMar 15, 2020